Related references
Note: Only part of the references are listed.The multiple roles and therapeutic potential of HSP60 in cancer
Yaoxiang Tang et al.
BIOCHEMICAL PHARMACOLOGY (2022)
Myasthenia gravis-specific aberrant neuromuscular gene expression by medullary thymic epithelial cells in thymoma
Yoshiaki Yasumizu et al.
NATURE COMMUNICATIONS (2022)
Aire and Fezf2, two regulators in medullary thymic epithelial cells, control autoimmune diseases by regulating TSAs: Partner or complementer?
Yanfei Qi et al.
FRONTIERS IN IMMUNOLOGY (2022)
Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study
Ruth Chia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics
Konstantinos Lazaridis et al.
FRONTIERS IN IMMUNOLOGY (2020)
Thymoma Associated Myasthenia Gravis (TAMG): Differential Expression of Functional Pathways in Relation to MG Status in Different Thymoma Histotypes
Yosuke Yamada et al.
FRONTIERS IN IMMUNOLOGY (2020)
Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial
Gil I. Wolfe et al.
LANCET NEUROLOGY (2019)
Alteration in gene expression profile of thymomas with or without myasthenia gravis linked with the nuclear factor-kappaB/autoimmune regulator pathway to myasthenia gravis pathogenesis
Feng Guo et al.
THORACIC CANCER (2019)
Myasthenia gravis
Nils Erik Gilhus et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Toll-like receptors 7 and 9 in myasthenia gravis thymus: amplifiers of autoimmunity?
Paola Cavalcante et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2018)
The Integrated Genomic Landscape of Thymic Epithelial Tumors
Milan Radovich et al.
CANCER CELL (2018)
Thymus involvement in early-onset myasthenia gravis
Melanie A. Cron et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2018)
Review on Toll-Like Receptor Activation in Myasthenia Gravis: Application to the Development of New Experimental Models
Marieke Robinet et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2017)
Thymic Germinal Centers and Corticosteroids in Myasthenia Gravis: an Immunopathological Study in 1035 Cases and a Critical Review
Frederique Truffault et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2017)
Prdm1 Regulates Thymic Epithelial Function To Prevent Autoimmunity
Natalie A. Roberts et al.
JOURNAL OF IMMUNOLOGY (2017)
Antigen processing and presentation in the thymus: implications for T cell repertoire selection
Kenta Kondo et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
Thymoma associated with autoimmune diseases: 85 cases and literature review
C. Bernard et al.
AUTOIMMUNITY REVIEWS (2016)
AIRE-mutations and autoimmune disease
Oyvind Bruserud et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
Estrogen-mediated downregulation of AIRE influences sexual dimorphism in autoimmune diseases
Nadine Dragin et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Randomized Trial of Thymectomy in Myasthenia Gravis
G. I. Wolfe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Thymoma related myasthenia gravis in humans and potential animal models
Alexander Marx et al.
EXPERIMENTAL NEUROLOGY (2015)
Thymic B Cells Are Licensed to Present Self Antigens for Central T Cell Tolerance Induction
Tomoyoshi Yamano et al.
IMMUNITY (2015)
Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart
William D. Travis et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Autoimmune regulator expression in thymomas with or without autoimmune disease
Yimei Liu et al.
IMMUNOLOGY LETTERS (2014)
Innate immunity in myasthenia gravis thymus: Pathogenic effects of Toll-like receptor 4 signaling on autoimmunity
Chiara Cordiglieri et al.
JOURNAL OF AUTOIMMUNITY (2014)
Central role of interferon-beta in thymic events leading to myasthenia gravis
Perrine Cufi et al.
JOURNAL OF AUTOIMMUNITY (2014)
ITMIG Consensus Statement on the Use of the WHO Histological Classification of Thymoma and Thymic Carcinoma: Refined Definitions, Histological Criteria, and Reporting
Alexander Marx et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
Etiology of myasthenia gravis: Innate immunity signature in pathological thymus
Paola Cavalcante et al.
AUTOIMMUNITY REVIEWS (2013)
The Molecular Anatomy of Human Hsp60 and its Similarity with that of Bacterial Orthologs and Acetylcholine Receptor Reveal a Potential Pathogenetic Role of Anti-Chaperonin Immunity in Myasthenia Gravis
Antonella Marino Gammazza et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2012)
THE THYMUS IN MYASTHENIA GRAVIS: SITE OF INNATE AUTOIMMUNITY?
Paola Cavalcante et al.
MUSCLE & NERVE (2011)
Thymoma-associated myasthenia gravis: Outcome, clinical and pathological correlations in 197 patients on a 20-year experience
Lorenzo Maggi et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
Clinical and pathological aspects of thymic epithelial tumors
Meinoshin Okumura et al.
GENERAL THORACIC AND CARDIOVASCULAR SURGERY (2008)
An IRF8-binding promoter variant and AIRE control CHRNA1 promiscuous expression in thymus
Matthieu Giraud et al.
NATURE (2007)
Outside looking in: the inner workings of the crosspresentation pathway within dendritic cells
Jose A. Villadangos et al.
TRENDS IN IMMUNOLOGY (2007)
Striational antibodies in myasthenia gravis - Reactivity and possible clinical significance
F Romi et al.
ARCHIVES OF NEUROLOGY (2005)
Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules
F Romi et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Share Paper
